| 1 |
35102335 | Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial. | 2022 Feb |
4 |
| 2 |
35172349 | [Adjuvant instillation therapy for non-muscle invasive bladder cancer - beyond BCG and mitomycin C]. | 2022 Apr |
1 |
| 3 |
35284622 | A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells. | 2022 Mar 17 |
3 |
| 4 |
33140189 | IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. | 2021 May |
4 |
| 5 |
33832946 | Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. | 2021 Jun 15 |
2 |
| 6 |
34244306 | Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing. | 2021 Jul |
1 |
| 7 |
34244307 | Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. | 2021 Jul |
2 |
| 8 |
34524494 | Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells. | 2021 Nov |
1 |
| 9 |
34578331 | Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection. | 2021 Sep 2 |
2 |
| 10 |
32163523 | The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques. | 2020 Mar |
2 |
| 11 |
32303618 | Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. | 2020 Apr |
1 |
| 12 |
32484854 | Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. | 2020 Jun 9 |
1 |
| 13 |
32669328 | Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques. | 2020 Sep 15 |
1 |
| 14 |
32913030 | Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study. | 2020 Sep |
4 |